Since vitamin C is a cofactor for TETs and enhances 5hmC generation11–15, supplementation of vitamin C might compensate for the decreased SVCT2 expression and oppose the loss of 5hmC in breast cancer. This evidence concerns the gene SLC23A2 and breast carcinoma.